Effectiveness of Clonidine in Child and Adolescent Sleep Disorders
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective We aimed to investigate the improvement in sleep quantity and quality when clonidine was used in children and adolescents with insomnia. We also examined how sociodemographic characteristics such as age, sex, underlying psychological problems, and levels of depression and anxiety affected the effect of clonidine.Methods We retrospectively reviewed outpatients aged 6 to 24 who took clonidine due to insomnia from September 2019 to September 2021 at the Department of Psychiatry at Eunpyeong St. Mary’s Hospital of Catholic University. We used the Pittsburgh Sleep Quality Index (PSQI), Children’s Depression Inventory (CDI), and State-Trait Anxiety Inventory (STAI) for our study.Results A total of 62 participants were included in our study (34 females, mean age 13.94±4.94 years). After using clonidine, there was a significant decrease in PSQI components 1, 2, and 5, especially PSQI component 2. There was a greater decrease in sleep latency when clonidine was used in females, those aged between 13 and 24, those with mood/anxiety disorder or attention-deficit/hyperactivity disorder, those whose sleep latency exceeded 60 minutes at baseline, and those who used clonidine for more than 14 days. Those with higher STAI-Trait scores and CDI scores at baseline showed less improvement in total PSQI scores.Conclusion Considering that there are currently no Food and Drug Administration-approved sleep drugs for children and adolescents and no apparent difference in efficacy and safety among sleep drugs, we demonstrated that treatment with clonidine might be a good approach to improve sleep quality and quantity for children and adolescents.
Abstract
Objective We aimed to investigate the improvement in sleep quantity and quality when clonidine was used in children and adolescents with insomnia. We also examined how sociodemographic characteristics such as age, sex, underlying psychological problems, and levels of depression and anxiety affected the effect of clonidine.Methods We retrospectively reviewed outpatients aged 6 to 24 who took clonidine due to insomnia from September 2019 to September 2021 at the Department of Psychiatry at Eunpyeong St. Mary’s Hospital of Catholic University. We used the Pittsburgh Sleep Quality Index (PSQI), Children’s Depression Inventory (CDI), and State-Trait Anxiety Inventory (STAI) for our study.Results A total of 62 participants were included in our study (34 females, mean age 13.94±4.94 years). After using clonidine, there was a significant decrease in PSQI components 1, 2, and 5, especially PSQI component 2. There was a greater decrease in sleep latency when clonidine was used in females, those aged between 13 and 24, those with mood/anxiety disorder or attention-deficit/hyperactivity disorder, those whose sleep latency exceeded 60 minutes at baseline, and those who used clonidine for more than 14 days. Those with higher STAI-Trait scores and CDI scores at baseline showed less improvement in total PSQI scores.Conclusion Considering that there are currently no Food and Drug Administration-approved sleep drugs for children and adolescents and no apparent difference in efficacy and safety among sleep drugs, we demonstrated that treatment with clonidine might be a good approach to improve sleep quality and quantity for children and adolescents.
참고문헌 (51)
- Owens J, "Classification and epidemiology of childhood sleep disorders", Sleep Med Clin, 2, pp.353~361 (2007)
- Lewien C, "Sleep-related difficulties in healthy children and adolescents", BMC Pediatr, 21, pp.82~ (2021)
- Liu X, "Insomnia and hypersomnia associated with depressive phenomenology and comorbidity in childhood depression", Sleep, 30, pp.83~90 (2007)
- Puig-Antich J, "Sleep architecture and REM sleep measures in prepubertal children with major depression: a controlled study", Arch Gen Psychiatry, 39, pp.932~939 (1982)
- Tikotzky L, "The role of cognitive-behavioral therapy in behavioral childhood insomnia", Sleep Med, 11, pp.686~691 (2010)
- Owens JA, "Pediatric insomnia", Pediatr Clin North Am, 58, pp.555~569 (2011)
- Owens JA, "Use of pharmacotherapy for insomnia in child psychiatry practice: a national survey", Sleep Med, 11, pp.692~700 (2010)
- Nguyen M, "A review of the use of clonidine as a sleep aid in the child and adolescent population", Clin Pediatr (Phila), 53, pp.211~216 (2014)
- Barrett JR, "To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit", hyperactivity disorder, 2013, pp.23, 640~647
- Schnoes CJ, "Pediatric prescribing practices for clonidine and other pharmacologic agents for children with sleep disturbance", Clin Pediatr (Phila), 45, pp.229~238 (2006)
- Yasaei R, "Clonidine" (2022), StatPearls Publishing
- Buysse DJ, "The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research", Psychiatry Res, 28, pp.193~213 (1989)
- Pilz LK, "Time to rethink sleep quality: PSQI scores reflect sleep quality on workdays", Sleep, 41, pp.zsy029~ (2018)
- Sohn SI, "The reliability and validity of the Korean version of the Pittsburgh Sleep Quality Index", Sleep Breath, 16, pp.803~812 (2012)
- Kovacs M, "Children’s depression inventory manual" (1992), Multi-Health Systems Inc
- Ozono S, "Reliability and validity of the children’s depression inventory-Japanese version", Pediatr Int, 61, pp.1159~1167 (2019)
- Cho SC, "Development of the Korean form of the Kovacs’ Children’s Depression Inventory", J Korean Neuropsychiatr Assoc, 29, pp.943~956 (1990)
- Spielberger CD, "Manual for the state-trait anxietry, inventory" (1970), Consulting Psychologist
- Julian LJ, "Measures of anxiety", Arthritis Care Res (Hoboken), 63(Suppl 11), pp.S467~S472 (2011)
- Paruthi S, "Consensus statement of the American Academy of Sleep Medicine on the recommended amount of sleep for healthy children: methodology and discussion", J Clin Sleep Med, 12, pp.1549~1561 (2016)
- MacLeod RL, "Innovations in practice: ‘off-label’ clonidine:UK paediatric and child and adolescent psychiatry prescribing practice for sleep problems", Child Adolesc Ment Health, 19, pp.147~150 (2014)
- Ming X, "Use of clonidine in children with autism spectrum disorders", Brain Dev, 30, pp.454~460 (2008)
- Ingrassia A, "The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders--a case series", Eur Child Adolesc Psychiatry, 14, pp.34~40 (2005)
- Del Rio G, "Sex differences in catecholamine response to clonidine", Int J Obes Relat Metab Disord, 17, pp.465~469 (1993)
- Schlarb AA, "Sleep duration and sleep problems in a representative sample of German children and adolescents", Health, 7, pp.1397~1408 (2015)
- Carskadon MA, "Regulation of adolescent sleep:implications for behavior", Ann N Y Acad Sci, 1021, pp.276~291 (2004)
- Au R, "School start times for adolescents", Pediatrics, 134, pp.642~649 (2014)
- Almondes KMD, "Sleep", wake cycle pattern and its relationship with anxiety in college students, 2003, pp.8, 37~43
- Corkum P, "Sleep disturbances in children with attention-deficit", hyperactivity disorder, 1998, pp.37, 637~646
- Sung V, "Sleep problems in children with attention-deficit", hyperactivity disorder: prevalence and the effect on the child and family, 2008, pp.162, 336~342
- Lecendreux M, "Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future", Expert Rev Neurother, 7, pp.1799~1806 (2007)
- Stein MA, "ADHD by night: sleep problems and ADHD medications", Child Adolesc Psychopharmacol News, 12, pp.1~5 (2007)
- Committee on Quality Improvement, "Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit", hyperactivity disorder, 2000, pp.105, 1158~1170
- Ivanenko A, "Sleep disturbances in children with psychiatric disorders", Semin Pediatr Neurol, 15, pp.70~78 (2008)
- Alfano CA, "Sleep-related problems among children and adolescents with anxiety disorders", J Am Acad Child Adolesc Psychiatry, 46, pp.224~232 (2007)
- Forbes EE, "Objective sleep in pediatric anxiety disorders and major depressive disorder", J Am Acad Child Adolesc Psychiatry, 47, pp.148~155 (2008)
- Lahmeyer HW, "EEG sleep in depressed adolescents", Am J Psychiatry, 140, pp.1150~1153 (1983)
- Jindal RD, "Treatment of insomnia associated with clinical depression", Sleep Med Rev, 8, pp.19~30 (2004)
- Croxtall JD, "Clonidine extended-release: in attention-deficit hyperactivity disorder", Paediatr Drugs, 13, pp.329~336 (2011)
- Haydon RC 3rd, "Are second-generation antihistamines appropriate for most children and adults?", Arch Otolaryngol Head Neck Surg, 127, pp.1510~1514 (2001)
- Meltzer EO, "Comparative safety of H1 antihistamines", Ann Allergy, 67, pp.625~633 (1991)
- Troester MM, "Pediatric sleep pharmacology: a primer", Semin Pediatr Neurol, 22, pp.135~147 (2015)
- Merenstein D, "The trial of infant response to diphenhydramine: the TIRED study--a randomized, controlled, patient-oriented trial", Arch Pediatr Adolesc Med, 160, pp.707~712 (2006)
- Baker AM, "Fatal diphenhydramine intoxication in infants", J Forensic Sci, 48, pp.425~428 (2003)
- Goodman LS, "Goodman and Gilman’s the pharmacological basis of therapeutics" (1996), McGraw-Hill
- Camfield P, "Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six “N of 1” trials", J Child Neurol, 11, pp.341~343 (1996)
- Bendz LM, "Melatonin treatment for insomnia in pediatric patients with attention-deficit", hyperactivity disorder, 2010, pp.44, 185~191
- Abdelgadir IS, "Melatonin for the management of sleep problems in children with neurodevelopmental disorders:a systematic review and meta-analysis", Arch Dis Child, 103, pp.1155~1162 (2018)
- Delbarre B, "Sedative effects of alpha-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs", Eur J Pharmacol, 13, pp.356~363 (1971)
- "Clonidine hydrochloride label"[URL]
- Klein-Schwartz W, "Trends and toxic effects from pediatric clonidine exposures", Arch Pediatr Adolesc Med, 156, pp.392~396 (2002)